Table 3.
Expression profiling of endothelial cells (ECs).
| Target tissue | Experimental treatment | Number of genes affected |
|---|---|---|
| Aortic EC [36] | Disturbed flow and steady laminar flow | 100 |
| Coronary artery [38] | Oxidised low-density lipoprotein | 78 |
| Coronary artery [40] | Infection with Chlamydia pneumoniae | 268 |
| Coronary artery [46] | Homocysteine | 600 |
| Coronary artery [48] | Nicotine | 4 |
| Umbilical vein [49] | BO-653, probucol and bento(h)quinoline (BHQ) | 17 |
| Smooth muscle cells (SMCs) from plaque [50] | SMCs + tumour necrosis factor (TNF)-α | 5 |
| Umbilical vein [30] | Interleukin-1 β and TNF-α | 209 EC + 39 in SMCs |